Tag Archives: NWBO

Top 10 Stocks To Buy Right Now

This article is reprinted by permission from NextAvenue.org.

While I certainly hope that no one reading this is currently involved in a fight with their life insurer over the rising costs of their universal life premiums, I know better.

Over just the last two years, tens of thousands of universal life policyholders have been hit with double-digit premium increases from companies such as Axa Equitable, Voya Financial
VOYA, +0.96%
 and Transamerica. More premium hikes, especially to longtime policyholders, are expected.

Top 10 Stocks To Buy Right Now: Prestige Brand Holdings Inc.(PBH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Prestige Brands Holdings, Inc. (NYSE:PBH) – Investment analysts at Gabelli cut their FY2019 earnings estimates for shares of Prestige Brands in a research report issued on Tuesday, July 3rd. Gabelli analyst Z. Bodini now anticipates that the company will post earnings of $3.00 per share for the year, down from their prior forecast of $3.05. Gabelli also issued estimates for Prestige Brands’ FY2020 earnings at $3.35 EPS, FY2021 earnings at $3.75 EPS, FY2022 earnings at $4.20 EPS and FY2023 earnings at $4.65 EPS.

  • [By Stephan Byrd]

    Premium Brands Holdings Corp (TSE:PBH) Director Stephen Sposari sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, May 25th. The stock was sold at an average price of C$117.01, for a total transaction of C$351,030.00.

  • [By Max Byerly]

    Premium Brands Holdings Corp (TSE:PBH) has earned an average recommendation of “Buy” from the seven analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is C$132.14.

Top 10 Stocks To Buy Right Now: Northwest Biotherapeutics, Inc.(NWBO)

Advisors’ Opinion:

  • [By ]

    Northwest Biotherapeutics (OTC:NWBO) presented underwhelming preliminary data from a late-stage study of DCVax-L in brain cancer.

    Community Health Systems (NYSE:CYH) amended to extend the “Early Tender Deadline” and the “Expiration Date” for each Exchange Offer announced earlier.

  • [By ]

    The last time we left Northwest Biotherapeutics (OTC:NWBO), I stated in a fairly cautious article that there are persistent risks associated with an investment in this company. Back in November, I did not feel that the benefits outweighed the risks for this small cap equity.

Top 10 Stocks To Buy Right Now: A V Homes, Inc.(AVHI)

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    Shares of AV Homes (NASDAQ:AVHI) have soared today, up by 29% as of 1:40 p.m. EDT, after the company announced it was being acquired. Larger homebuilder Taylor Morrison Home Corporation (NYSE:TMHC) is scooping up AV Homes in a $1 billion deal.

  • [By Joseph Griffin]

    Headlines about AV Homes (NASDAQ:AVHI) have been trending somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. AV Homes earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned news headlines about the financial services provider an impact score of 44.8950832122121 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

Top 10 Stocks To Buy Right Now: DXP Enterprises Inc.(DXPE)

Advisors’ Opinion:

  • [By Shane Hupp]

    American Century Companies Inc. decreased its holdings in DXP Enterprises Inc (NASDAQ:DXPE) by 40.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 159,977 shares of the industrial products company’s stock after selling 106,808 shares during the quarter. American Century Companies Inc.’s holdings in DXP Enterprises were worth $6,111,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Press coverage about DXP Enterprises (NASDAQ:DXPE) has been trending somewhat positive on Thursday, Accern Sentiment reports. The research group rates the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. DXP Enterprises earned a coverage optimism score of 0.22 on Accern’s scale. Accern also assigned media headlines about the industrial products company an impact score of 44.8189875544661 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Logan Wallace]

    American Century Companies Inc. decreased its position in DXP Enterprises, Inc. (NASDAQ:DXPE) by 63.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 266,785 shares of the industrial products company’s stock after selling 454,667 shares during the quarter. American Century Companies Inc. owned approximately 1.54% of DXP Enterprises worth $10,391,000 at the end of the most recent reporting period.

  • [By Motley Fool Transcribers]

    DXP Enterprises Inc  (NASDAQ:DXPE)Q4 2018 Earnings Conference CallMarch 07, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    DXP Enterprises (NASDAQ:DXPE) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued on Thursday.

  • [By Joseph Griffin]

    News stories about DXP Enterprises (NASDAQ:DXPE) have been trending somewhat positive on Saturday, according to Accern. Accern scores the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. DXP Enterprises earned a media sentiment score of 0.21 on Accern’s scale. Accern also gave news headlines about the industrial products company an impact score of 46.1699723331071 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Top 10 Stocks To Buy Right Now: Norwood Financial Corp.(NWFL)

Advisors’ Opinion:

  • [By Max Byerly]

    Media headlines about Norwood Financial (NASDAQ:NWFL) have trended somewhat negative this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Norwood Financial earned a coverage optimism score of -0.01 on Accern’s scale. Accern also assigned news coverage about the financial services provider an impact score of 46.6420547965898 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 10 Stocks To Buy Right Now: iShares MSCI All Peru Capped ETF (EPU)

Advisors’ Opinion:

  • [By Max Byerly]

    iShares MSCI All Peru Capped Index Fund (BMV:EPU) declared a semiannual dividend on Wednesday, June 20th, Wall Street Journal reports. Shareholders of record on Wednesday, June 20th will be given a dividend of 0.3845 per share on Monday, June 25th. This represents a yield of 1.91%. The ex-dividend date of this dividend is Tuesday, June 19th.

Top 10 Stocks To Buy Right Now: CareDx, Inc.(CDNA)

Advisors’ Opinion:

  • [By Brian Orelli]

    Shares of transplant specialist CareDx (NASDAQ:CDNA) jumped 13.5% on Friday after the company reported solid second-quarter earnings after the bell on Thursday, leading management to raise guidance for the year.

  • [By Shane Hupp]

    Genomic Health (NASDAQ: GHDX) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

  • [By Max Byerly]

    CareDx Inc (NASDAQ:CDNA) CFO Michael Brian Bell sold 16,355 shares of the business’s stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $25.06, for a total value of $409,856.30. Following the completion of the transaction, the chief financial officer now directly owns 52,238 shares of the company’s stock, valued at approximately $1,309,084.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

  • [By Joseph Griffin]

    Craig Hallum set a $35.00 target price on CareDx (NASDAQ:CDNA) in a research report sent to investors on Wednesday morning, The Fly reports. The firm currently has a buy rating on the stock.

Top 10 Stocks To Buy Right Now: Illinois Tool Works Inc.(ITW)

Advisors’ Opinion:

  • [By ]

    In the Lightning Round, Cramer was bullish on Idexx Laboratories (IDXX) , XPO Logistics (XPO) , Diamondback Energy (FANG) and Illinois Tool Works (ITW) .

  • [By ]

    Illinois Tools Works (ITW) shares fell after the company’s earnings report, but Cramer and the AAP team see it as an opportunity to buy more shares. Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By ]

    Illinois Tools Works (ITW) shares fell after the company’s earnings report, but Cramer and the AAP team see it as an opportunity to buy more shares. Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Top 10 Stocks To Buy Right Now: Home Federal Bancorp Inc.(HOME)

Advisors’ Opinion:

  • [By Shane Hupp]

    Jefferies Financial Group Inc began coverage on shares of At Home Group (NYSE:HOME). They issued a buy rating and a $45.00 target price on the stock.

  • [By ]

    Real Money columnist Robert Lang says that while retail “has certainly had its challenges over the past couple of years, between difficulties in the mall and then the big gorilla in the room, Action Alerts PLUS holding Amazon (AMZN) …there are a handful of names that continue to perform well, one of those is At Home Group (HOME) .

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on At Home Group (HOME)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Buy Right Now: MakeMyTrip Limited(MMYT)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In this segment from Motley Fool Money, host Chris Hill asks analysts Jason Moser, David Kretzmann, and Andy Cross to give us the lowdown on some companies that caught their attention recently. Their picks this week are stun gun and body-cam leader Axon Enterprise (NASDAQ:AAXN), home-improvement retailer Home Depot (NYSE:HD), and Indian online travel agency MakeMyTrip (NASDAQ:MMYT).

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on MakeMyTrip (MMYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    MakeMyTrip Limited (NASDAQ:MMYT) hit a new 52-week high and low during trading on Tuesday . The stock traded as low as $41.70 and last traded at $40.35, with a volume of 24850 shares trading hands. The stock had previously closed at $39.10.

  • [By Max Byerly]

    MakeMyTrip (NASDAQ: MMYT) and Yatra Online (NASDAQ:YTRA) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

  • [By Max Byerly]

    TheStreet lowered shares of MakeMyTrip (NASDAQ:MMYT) from a c- rating to a d+ rating in a report published on Tuesday.

    Other equities research analysts also recently issued reports about the stock. Jefferies Financial Group raised shares of MakeMyTrip from a hold rating to a buy rating and set a $19.80 price target for the company in a research note on Wednesday, August 15th. BidaskClub downgraded shares of MakeMyTrip from a strong-buy rating to a buy rating in a research note on Wednesday, June 20th. Zacks Investment Research raised shares of MakeMyTrip from a hold rating to a buy rating and set a $45.00 price target for the company in a research note on Friday, June 15th. Bank of America dropped their price target on shares of MakeMyTrip from $40.00 to $39.50 and set a buy rating for the company in a research note on Monday, July 9th. Finally, ValuEngine downgraded shares of MakeMyTrip from a buy rating to a hold rating in a research note on Thursday, September 6th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of $36.36.

  • [By Shane Hupp]

    Nomura upgraded shares of MakeMyTrip (NASDAQ:MMYT) from a reduce rating to a neutral rating in a report issued on Monday morning, Marketbeat reports.

Best Casino Stocks To Own For 2019

Third Point, the activist fund run by Dan Loeb, exited a series of high-profile positions during the first quarter, including stakes in Honeywell International Inc., Time Warner Inc., MGM Resorts International and U.S. mall owner Macerich Co.

The New York-based hedge fund also added a position in Wynn Resorts Ltd., according to a regulatory filing Tuesday. The Las Vegas-based casino company’s co-founder and chief executive officer, Steve Wynn, resigned in February amid allegations of sexual harassment. Wynn Resorts made a surprise announcement Monday that two directors were resigning, including one who co-founder Elaine Wynn urged shareholders to vote against.

Land & Buildings Investment Management, the activist fund run by Jonathan Litt, also disclosed a stake in Wynn Resorts Tuesday.

Third Point’s exit of Macerich comes after that company announced last month that Chief Executive Officer Arthur Coppola would retire at the end of the year.

Best Casino Stocks To Own For 2019: Northwest Biotherapeutics, Inc.(NWBO)

Advisors’ Opinion:

  • [By ]

    The last time we left Northwest Biotherapeutics (OTC:NWBO), I stated in a fairly cautious article that there are persistent risks associated with an investment in this company. Back in November, I did not feel that the benefits outweighed the risks for this small cap equity.

  • [By ]

    Northwest Biotherapeutics (OTC:NWBO) presented underwhelming preliminary data from a late-stage study of DCVax-L in brain cancer.

    Community Health Systems (NYSE:CYH) amended to extend the “Early Tender Deadline” and the “Expiration Date” for each Exchange Offer announced earlier.

Best Casino Stocks To Own For 2019: Inter Parfums, Inc.(IPAR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Inter Parfums (IPAR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Inter Parfums (IPAR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Inter Parfums (IPAR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Inter Parfums, Inc. (NASDAQ:IPAR) – Investment analysts at DA Davidson reduced their Q3 2018 earnings per share (EPS) estimates for Inter Parfums in a note issued to investors on Thursday, August 9th. DA Davidson analyst L. Weiser now forecasts that the company will earn $0.62 per share for the quarter, down from their previous forecast of $0.65. DA Davidson currently has a “Buy” rating and a $72.00 target price on the stock. DA Davidson also issued estimates for Inter Parfums’ Q4 2018 earnings at $0.11 EPS.

Best Casino Stocks To Own For 2019: Coupa Software Incorporated (COUP)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Coupa Software Incorporated (NASDAQ:COUP)Q1 2019 Earnings Conference CallJune 4, 2018, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Coupa Software Inc (NASDAQ:COUP) CEO Robert Bernshteyn sold 63,225 shares of the firm’s stock in a transaction dated Friday, August 17th. The stock was sold at an average price of $66.73, for a total value of $4,219,004.25. Following the transaction, the chief executive officer now owns 204,218 shares of the company’s stock, valued at $13,627,467.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Shane Hupp]

    Coupa Software Inc (NASDAQ:COUP)’s share price reached a new 52-week high and low during mid-day trading on Monday following a stronger than expected earnings report. The company traded as low as $55.48 and last traded at $55.30, with a volume of 77934 shares trading hands. The stock had previously closed at $54.92.

  • [By Stephan Byrd]

    Coupa Software (NASDAQ:COUP) had its target price upped by Morgan Stanley from $57.00 to $62.00 in a research report sent to investors on Tuesday. The brokerage currently has an equal weight rating on the technology company’s stock.

  • [By Shane Hupp]

    Shares of Coupa Software Inc (NASDAQ:COUP) have been assigned an average rating of “Buy” from the eighteen brokerages that are currently covering the firm, Marketbeat.com reports. Seven investment analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $51.56.

  • [By Ethan Ryder]

    Coupa Software Inc (NASDAQ:COUP) CEO Robert Bernshteyn sold 5,558 shares of the firm’s stock in a transaction on Thursday, June 21st. The stock was sold at an average price of $63.61, for a total value of $353,544.38. Following the sale, the chief executive officer now directly owns 141,265 shares of the company’s stock, valued at $8,985,866.65. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Top Medical Stocks To Invest In Right Now

Cyndee Weston can barely remember the last time she didn’t have to switch health plans during an Affordable Care Act sign-up season. By her count, she has been on five plans in five years.

Every fall, after she has spent months figuring out her insurance plan’s deductibles, doctor networks, list of covered drugs and other fine print, she receives notice that the policy will be canceled as of Dec. 31.

Because her job doesn’t come with insurance, “it’s agonizing going through all the plans and trying to compare,” said Weston, 55, who has diabetes and a history of melanoma. “Every year it’s the same scenario: ‘We’re not going to renew your policy.'”

Under the market-based system set up by the ACA, individuals are encouraged to “shop around” each year to find insurance that better suits their medical needs and income. In fact like Weston, a trade association executive in Sulphur, Okla. they are often forced to do so when plans drop out of the local market or eliminate preferred hospitals and doctors from the network.

Top Medical Stocks To Invest In Right Now: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Spark Therapeutics (NASDAQ:ONCE) was the target of some unusual options trading activity on Thursday. Investors acquired 551 put options on the company. This represents an increase of 884% compared to the average volume of 56 put options.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Spark Therapeutics (ONCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    So, which biotech stocks should you consider buying in June? That’s a question we posed to three of our healthcare-focused investors. Interestingly enough, mid-cap biotech stocks are the clear flavor of the month. If biotech is on your radar in June, our investors suggest you consider Ionis Pharmaceuticals (NASDAQ:IONS), Spark Therapeutics (NASDAQ:ONCE), and Alnylam Pharmaceuticals (NASDAQ:ALNY).

  • [By Cory Renauer]

    Here’s what you need to know about the catalysts that could send these stocks soaring, or plummeting, in the third quarter.

    Company Market Cap Incoming Catalyst
    Spark Therapeutics Inc. (NASDAQ:ONCE) $3.09 billion Clinical trial results
    Zogenix, Inc. (NASDAQ:ZGNX) $1.56 billion Clinical trial results
    Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) $593 million PDUFA date

    Data source: Yahoo! Finance.

  • [By Shane Hupp]

    Spark Therapeutics (NASDAQ:ONCE)‘s stock had its “market perform” rating reiterated by Leerink Swann in a research report issued on Monday, The Fly reports. They currently have a $74.00 price objective on the biotechnology company’s stock, up from their previous price objective of $55.00. Leerink Swann’s price objective would indicate a potential upside of 4.71% from the stock’s current price.

  • [By Ethan Ryder]

    FIL Ltd cut its stake in Spark Therapeutics Inc (NASDAQ:ONCE) by 9.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,134 shares of the biotechnology company’s stock after selling 8,084 shares during the period. FIL Ltd owned approximately 0.21% of Spark Therapeutics worth $5,270,000 at the end of the most recent reporting period.

Top Medical Stocks To Invest In Right Now: Northwest Biotherapeutics, Inc.(NWBO)

Advisors’ Opinion:

  • [By ]

    Northwest Biotherapeutics (OTC:NWBO) presented underwhelming preliminary data from a late-stage study of DCVax-L in brain cancer.

    Community Health Systems (NYSE:CYH) amended to extend the Early Tender Deadline and the Expiration Date for each Exchange Offer announced earlier.

  • [By ]

    The last time we left Northwest Biotherapeutics (OTC:NWBO), I stated in a fairly cautious article that there are persistent risks associated with an investment in this company. Back in November, I did not feel that the benefits outweighed the risks for this small cap equity.

Top Medical Stocks To Invest In Right Now: Dawson Geophysical Company(DWSN)

Advisors’ Opinion:

  • [By Max Byerly]

    Dawson Geophysical (NASDAQ:DWSN) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Monday.

  • [By Logan Wallace]

    Dawson Geophysical (NASDAQ:DWSN) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c-” rating in a research note issued on Monday.

Top Medical Stocks To Invest In Right Now: TripAdvisor, Inc.(TRIP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Booking Holdings Inc. (NASDAQ: BKNG) to post quarterly earnings at $10.67 per share on revenue of $2.87 billion after the closing bell. Booking Holdings shares gained 0.99 percent to $2,183.00 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) reported stronger-than-expected results for its first quarter on Tuesday. Tripadvisor shares climbed 20.55 percent to $46.75 in the after-hours trading session.
    Analysts are expecting Anheuser-Busch InBev SA/NV (NYSE: BUD) to have earned $0.89 per share on revenue of $13.06 billion in the latest quarter. Anheuser-Busch will release earnings before the markets open. Anheuser-Busch shares gained 0.77 percent to $99.00 in after-hours trading.
    Extreme Networks, Inc (NASDAQ: EXTR) reported downbeat earnings for its third quarter and issued weak Q4 guidance. Extreme Networks shares fell 28.51 percent to $8.40 in the after-hours trading session.
    Before the opening bell, Ameren Corporation (NYSE: AEE) is projected to report quarterly earnings at $0.57 per share on revenue of $1.55 billion. Ameren shares dropped 2.78 percent to close at $56.91 on Tuesday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Dan Caplinger]

    The stock market jumped on Wednesday, with the Dow Jones Industrial Average finishing up by triple digits and other major benchmarks following suit with similar-sized gains. Attention once again focused on the oil market, where prices rebounded to climb to new multiyear highs above $71 per barrel. Investors seem to see oil’s strength as indicating stronger levels of economic activity, choosing not to fear any adverse pressure on prices that could result from higher costs for consumers and businesses that rely on energy products. Good news from several individual companies also helped keep sentiment positive. Axon Enterprise (NASDAQ:AAXN), TripAdvisor (NASDAQ:TRIP), and iQiyi (NASDAQ:IQ) were among the best performers on the day. Here’s why they did so well.

  • [By Demitrios Kalogeropoulos]

    TripAdvisor’s(NASDAQ:TRIP) business is barely growing, but Wall Street couldn’t be happier. The online travel booking specialist’s stock jumped over 20% immediately following its first-quarter earnings report that showed a 2% sales uptick while earnings fell 62% to $5 million.

  • [By Adam Levy]

    If you looked at the recent stock performances of TripAdvisor (NASDAQ:TRIP) and Booking Holdings (NASDAQ:BKNG), TripAdvisor has been, by far, the better investment. But zooming out to look at their respective price changes over the last several years tells a much different story.

  • [By Lisa Levin] Gainers
    Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday.
    ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results.
    OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat.
    Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday.
    KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday.
    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings.
    New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results.
    Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings.
    Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top Medical Stocks To Invest In Right Now: J & J Snack Foods Corp.(JJSF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ValuEngine upgraded shares of J & J Snack Foods (NASDAQ:JJSF) from a hold rating to a buy rating in a research note issued to investors on Tuesday.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com